ER
Esther Rajavelu UBS Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Ionis Pharmaceuticals
IONS
$9.76B
| $61.23 | $46 |
25%
downside
| Neutral | 24 days ago |
|
2
Denali Therapeutics
DNLI
$2.26B
| $15.44 | $32 |
107%
upside
| Buy | 1 year ago |
|
3
Alnylam Pharmaceuticals
ALNY
$59.2B
| $451.99 | $215 |
52%
downside
| Buy | 3 years ago |
|
4
Ultragenyx Pharmaceutical
RARE
$3.06B
| $31.79 | $73 |
130%
upside
| Sell | 4 years ago |
|
5
Biohaven
BHVN
$1.68B
| $15.86 | $109 |
587%
upside
| Neutral | 4 years ago |
|
6
Stoke Therapeutics
STOK
$1.14B
| $20.72 | $35 |
69%
upside
| Neutral | 4 years ago |
|
7
Jazz Pharmaceuticals
JAZZ
$7.86B
| $129.53 | $228 |
76%
upside
| Buy | 4 years ago |
|
|
8
Ionis Pharmaceuticals
IONS
$9.76B
| $61.23 | $74 |
21%
upside
| Outperform | 5 years ago |
|
|
9
Biohaven
BHVN
$1.68B
| $15.86 | $37 |
133%
upside
| Perform | 5 years ago |
|